Dragnev, K. H., Erman, M., Bria, E., Lee, J. M., Manschot, C., Thompson, J., Samkari, A., Spicer, J. (2025). KEYMAKER-U01E: A phase 2 umbrella study with rolling arms of investigational agents with or without chemotherapy plus pembrolizumab for resectable stage II–IIIB (N2) non–small-cell lung cancer (NSCLC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps8115